Bouma et al., 1975 - Google Patents
Factor VIII Related Antigen in Normal Blood Platelets and in Platelets of Patients with von Willebrand's DiseaseBouma et al., 1975
View PDF- Document ID
- 5643864408078030801
- Author
- Bouma B
- Hordijk-Hos J
- de Graaf S
- van Mourik J
- Sixma J
- Publication year
- Publication venue
- Thrombosis and Haemostasis
External Links
Snippet
The presence of Factor VIII-related antigen (F VIIIRA) in haemostatic plugs was demonstrated by immunofluorescent techniques. Immunofluorescent studies of intact washed platelets incubated with rabbit antifactor VIII in suspension showed that most of the …
- 210000001772 Blood Platelets 0 title abstract description 29
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/37—Factors VIII
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/30—Macromolecular compounds
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin, zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Aggeler et al. | Plasma throinboplastin component (PTC) deficiency: A new disease resembling hemophilia | |
JP3701028B2 (en) | How to obtain high purity von Willebrand factor | |
US5792835A (en) | Method of preparing a topical fibrinogen complex | |
Nilsson et al. | Characteristics of various factor VIII concentrates used in treatment of haemophilia A | |
EP0217341B2 (en) | Process for preparing an anticoagulating substance | |
AU2005228945B2 (en) | Factor IXa for the treatment of bleeding disorders | |
BG61231B1 (en) | A method for isolating factor viii | |
Berntorp et al. | Use of a high-purity factor VIII concentrate (Hemate P) in von Willebrand’s disease | |
JPH07501517A (en) | topical fibrinogen complex | |
DK164282B (en) | BIOLOGICALLY ACTIVE FRAGMENTS OF HUMAN ANTIHAEMOPHILIC FACTOR VIII: C, USE OF THE FRAGMENTS AND PROCEDURE FOR PREPARING THEM | |
WO1995025748A1 (en) | Topical fibrinogen complex | |
Bouma et al. | Presence of factor VIII-related antigen in blood platelets of patients with von Willebrand's disease | |
JPH09221432A (en) | Medicine preparation containing von willebrand's factor | |
Molnar et al. | The role of an α2-macroglobulin of rat serum in the phagocytosis of colloidal particles | |
JPH0424360B2 (en) | ||
JPH0553777B2 (en) | ||
Nilsson et al. | Characteristics of the factor VIII protein and factor XIII in various factor VIII concentrates | |
Cumming et al. | Clinical and laboratory evaluation of National Health Service factor VIII concentrate (8Y) for the treatment of von Willebrand's disease | |
Booth et al. | An altered platelet granule glycoprotein in patients with essential thrombocythemia. | |
Bouma et al. | Factor VIII Related Antigen in Normal Blood Platelets and in Platelets of Patients with von Willebrand’s Disease | |
AU674061B2 (en) | Factor XIII for treatment of skin wounds | |
Bowie et al. | Transfusion and autotransfusion of plasma in von Willebrand's disease | |
Almasio et al. | Characterization of the molecular forms of fibronectin in fulminant hepatic failure | |
Marcus et al. | Purification and properties of porcine platelet aggregating factor | |
Johnson et al. | Relationship of platelet factor 1 and platelet fibrinogen to plasma |